abstract |
The present invention relates to a method of treating cutaneous cutaneous lymphoma (CTCL), in particular fungoid mycosis and / or Sézary syndrome, which method comprises administering to a patient in need thereof a therapeutically effective amount of an antagonist antibody or binding fragment thereof, specific for the IL-13 receptor. |